stand4hope Posted March 16, 2005 Share Posted March 16, 2005 New Advances in the Management of Advanced NSCLC: The Expanding Role of Targeted Therapies (Live CME Web Conference) Recent contradictory findings have raised new questions about the role of tyrosine kinase inhibitors in the treatment of advanced NSCLC. Join us on Wednesday, March 23, at 2 PM EST, for a Web-based, CME-certified live conference as Drs. Roman Perez-Soler and Vincent Miller explore the promise and the pitfalls of targeted therapy in this setting. If the link above, Live CME Web Conference) doesn't work, try this: http://www.medscape.com/viewprogram/3929?src=mp or this: http://mp.medscape.com/cgi-bin1/DM/y/hm ... 1H0GU5W0E1 Quote Link to comment Share on other sites More sharing options...
Join the conversation
You can post now and register later. If you have an account, sign in now to post with your account.